Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1992-12-8
|
pubmed:abstractText |
The T cell surface molecule CD2 forms, with its counter-receptor CD58 (LFA-3), a powerful adhesion/activation pathway. There is some evidence that CD2 might bind more than a single ligand. Chinese hamster ovary cells (CHO) expressing human CD59 after cDNA transfection (CD59+CHO) form rosettes with human T cells; these rosettes are inhibited in a dose-dependent fashion by the CD59 monoclonal antibody (mAb) H19 and by the CD2 mAb O275 known to block natural rosettes, but not by the CD2R mAb D66, a poor rosette blocker. CD2+CHO transfectants form rosettes with human erythrocytes; these rosettes are inhibited by the CD59 mAb H19 in addition to CD2 mAb O275 and CD58 mAb; murine thymoma cells expressing human CD2 form rosettes with CD59+CHO cells that again are blocked by CD59 H19 and by CD2 O275 mAb. In a marked contrast with H19, two others CD59 mAb, YTH 53.1 and MEM 43, which react with a different epitope on CD59, led to a 50%-70% increase of the number of cells forming rosettes. In addition to rosette experiments, the binding of 125I-labeled CD59 molecules to CD2+CHO cells was specifically inhibited by unlabeled CD59 molecule and CD2 mAb. Furthermore, the binding of CD59 molecules to resting T cells induced expression of CD2R epitopes. These results directly show that CD2 binds CD59 and that subtle molecular changes occur upon binding.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD2,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD59,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2943-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1385156-Animals,
pubmed-meshheading:1385156-Antigens, CD,
pubmed-meshheading:1385156-Antigens, CD2,
pubmed-meshheading:1385156-Antigens, CD59,
pubmed-meshheading:1385156-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:1385156-CHO Cells,
pubmed-meshheading:1385156-Cell Adhesion,
pubmed-meshheading:1385156-Cells, Cultured,
pubmed-meshheading:1385156-Cricetinae,
pubmed-meshheading:1385156-Epitopes,
pubmed-meshheading:1385156-Humans,
pubmed-meshheading:1385156-Ligands,
pubmed-meshheading:1385156-Membrane Glycoproteins,
pubmed-meshheading:1385156-Receptors, Immunologic,
pubmed-meshheading:1385156-T-Lymphocytes,
pubmed-meshheading:1385156-Transfection
|
pubmed:year |
1992
|
pubmed:articleTitle |
CD59 molecule: a second ligand for CD2 in T cell adhesion.
|
pubmed:affiliation |
INSERM U343, Faculté de Médecine, Nice, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|